Omega-3 Fatty Acid

Ayers: 360 days of sunlight

New entrant set to shake up algal omega-3 market

By Elaine Watson

A new player is poised to enter the vegetarian omega-3 market with a production process it claims will enable it to make the long chain fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) from algae at a fraction of the cost of rivals.

Lawyer: FDA line on grandfathered ingredients was not made clear

Lawyer: FDA line on grandfathered ingredients was not made clear

By Elaine Watson

A leading food law expert and the Food and Drug Administration’s (FDA’s) dietary supplements chief agreed to disagree over several key aspects of the FDA’s draft guidance on new dietary ingredients (NDIs) during a spirited conference call with stakeholders...

Martek: Onwards and upwards under new ownership

Martek predicts double-digit rise in sales to food & bev market

By Elaine Watson

Martek expects sales of its algal-sourced omega-3s to food and drink manufacturers to grow in the double-digits each year for the next four to five years as it broadens its product range and gains access to new markets and customers post its takeover...

If the pricetag looks too good to be true, it probably is ...

GOED/Neptune: Krill monograph will help firms detect genuine article

By Elaine Watson

Another leading supplier has weighed into the debate over unscrupulous firms peddling ‘krill oil’ that contains “next to no phospholipids” but says the development of a monograph and better testing protocols might go some way to tackling the problem.

Pure krill oil has a minimum of 40% phospholipids

Fake krill undermines whole market, warns Aker Biomarine

By Elaine Watson

Unscrupulous firms peddling ‘krill oil’ that contains “next to no phospholipids” risk denting confidence in the efficacy of krill and the broader omega-3 market, a leading supplier has warned.

EPA/DHA: How much is enough?

GOED: US food manufacturers want clarity on omega-3 DRIs

By Elaine Watson

Global omega-3 EPA and DHA organization GOED has heard positive signs that if and when a new Institute of Medicine (IOM) dietary reference intake (DRI) project is commissioned in the US, omega-3s will be “near the top of the list”.

Producing DHA from canola oil would be cheap and sustainable, says Dow

Dow: DHA from canola oil still ‘some years away’

By Elaine Watson

Dow Agrosciences and Martek Biosciences (now part of DSM) are progressing well with plans to develop canola oil containing the coveted long-chain omega-3 fatty acid DHA, but are still “a number of years” away from bringing something to market.

Eskimo study supports omega-3 for heart health

By Stephen Daniells

High intakes of omega-3 fatty acids may reduce the risk of obesity-related chronic diseases such as diabetes and heart disease, according to new findings from a study with Alaskan Eskimos.

A view to a krill

Krill oil may aid fat metabolism: Rat study

By Stephen Daniells

Daily supplements of krill oil may reduce cholesterol levels by 33 percent, and improve liver triglyceride levels, with results superior to fish oil, according to data from a rat study.

DHA, EPA, and dietary fish may reduce the risk of AMD and related vision loss.

Omega-3 may reduce risk of AMD vision loss

Omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) may significantly reduce the risk of developing age-related macular degeneration (AMD), according to new research.

Refining the omega-3 ‘policy gap’ that feeds global deficiencies

Refining the omega-3 ‘policy gap’ that feeds global deficiencies

By Shane Starling in Bruges

The omega-3 industry must devote more resources to lobbying and educating government, health care professionals and the general public to help plug a ‘policy gap’ that is contributing to a growing epidemic of cognitive disorders, a congress has been told.

Omega-3 may combat muscle loss associated with aging

Omega-3s may counter degenerative muscle loss: Study

By Stephen Daniells

Daily supplements of omega-3 fatty acids may boost the production of muscle protein in older people, and reduce the risk of degenerative muscle loss, suggest data from a new human trial.

Martek becomes DSM's biggest acquisition since its 2002 purchase of Roche Vitamins

DSM buys Martek’s “algae platform” for $1bn+

By Shane Starling

Royal DSM will drive Martek’s predominantly US-based, omega-3 DHA infant nutrition business to new shores, and fast-track its food and beverage ambitions, after having its billion-dollar bid accepted by the Maryland company’s Board.

Omega-3 group appoints new chairman

Omega-3 group appoints new chairman

By staff reporter

The Global Organization for EPA and DHA Omega-3 (GOED) has elected EPAX’s Baldur Hjaltason as its new chairman, replacing Croda’s David Shannon.

Jury still out on omega-3 for post-natal depression

Jury still out on omega-3 for post-natal depression

By Stephen Daniells

Reducing the risk of depression during pregnancy and after birth with supplements of omega-3 fatty acids is not backed up by the science-to-date, says a new meta-analysis and systematic review.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All